TuttoCongressi
E-mail
Password
 Resta Collegato

Cerca per parole nell'archivio:
In archivio:
  • N° Relazioni: 478
  • N° Accessi Relaz.: 168906
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

   Mostra tutti | Mostra contenuti EasyRec   
ABCDEFGHIJKLMNOPQRSTUVWXYZ
M
M. Delcroix 
What are the biological/pathological rationale and clinical evidence for medical treatment of CTEPH? Should approach to treatment factor in whether the patient is operable, deemed inoperable, or has persistent PH following endarterectomy?
M. Delcroix 
What are the biological/pathological rationale and clinical evidence for medical treatment of CTEPH? Should approach to treatment factor in whether the patient is operable, deemed inoperable, or has persistent PH following endarterectomy?
M. Hoeper 
Should we include rest PVR in the definition of PH and how do we define and handle "borderline" PH?
M. Hoeper 
Should we include rest PVR in the definition of PH and how do we define and handle "borderline" PH?
M. W. Geraci 
What application of genetic advances, such as miRNA, epigenetics for treatment and prevention of heritable PAH?
M. W. Geraci 
What application of genetic advances, such as miRNA, epigenetics for treatment and prevention of heritable PAH?
M.Gatzoulis 
Congenital Heart Disease
M.Gatzoulis 
Congenital Heart Disease
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali
Tuttocongressi ©1995 - 2026 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481